Selected Publications

Gupta A, Johnson WV, Henderson NL, Ogunleye OO, Sekar P, George M, Breininger A, Kyle MA, Booth CM, Hanna TP, Rocque GB, Parsons HM, Vogel RI, Blaes AH : Patient, Caregiver, and Clinician Perspectives on the Time Toxicity of Cancer Care: A Qualitative Analysis JAMA Network Open 7(11), Nov 2024.

Jung OS, Kyle MA, McCree P, Nadel HM.: Response to Letter to the Editor Regarding Our Paper, "Patient-Centered Innovation: Involving Patients in Open Social Innovation" Med Care Oct 2024.

Kakani P, Kyle MA, Maini L, Chandra A: The Association Between Medicare Part D Protected Classes and Pharmaceutical Rebates. Health Affairs 43(10): 1420 - 1427, October 2024.

Kyle MA, Keating NL.: The Promise and Perils of Oncology Care in Medicare Advantage. JAMA Netw Open 7(9): e2434650, Sep 2024.

Jung OS, Kyle MA, McCree P, Nadel HM.: Patient-Centered Innovation: Involving Patients in Open Social Innovation. Med Care 62: 314-318, May 2024.

Jung OS, Kyle MA, McCree P, Nadel H. : Correspondence: Involving Patients in Open Social Innovation: Effects of Patients’ Perceived Role in Innovation and Participation. Medical Care 62(5): 314 - 318, May 2024.

Kyle MA, Keating NL.: Prior Authorization and Association With Delayed or Discontinued Prescription Fills. J Clin Oncol 42: 951-960, Mar 2024.

Brown R, Petersen B, Buckley BO, Kyle MA, Glenn J. : How do cancer patients in economically marginalized neighborhoods decide where to seek care? Cancer Control Jan - Dec 2024.

Kakani P, Kyle MA, Chandra A, Maini L.: Medicare Part D Protected-Class Policy Is Associated With Lower Drug Rebates. Health Aff (Millwood) 2024.

Kyle MA, Song Z.: The Consequences and Future of Prior-Authorization Reform. N Engl J Med 389: 291-293, Jul 2023.